Kosa KM, Cates S, Godwin S, Chambers E. Barriers to using a food thermometer when cooking poultry at home: results from a national survey. Food Prot Trends. 2017 Mar;37(2):116-25.
Mauskopf J, Chirila C, Birt J, Boye KS, Bowman L. Drug reimbursement recommendations by the National Institute for Health and Clinical Excellence: have they impacted the National Health Service budget? Health Policy (New York). 2013 Apr 1;110(1):49-59.
Dickey H, Ikenwilo D, Norwood P, Watson V, Zangelidis A. Utilisation of eye-care services: the effect of Scotland's free eye examination policy. Health Policy (New York). 2012 Dec;108(2-3):286-93. doi: 10.1016/j.healthpol.2012.09.006
Watson V, Sussex J, Ryan M, Tetteh E. Managing poorly performing clinicians: health care providers' willingness to pay for independent help. Health Policy (New York). 2012 Mar;104(3):260-71. doi: 10.1016/j.healthpol.2011.12.006
Kosa KM, Cates SC, Goodwin SL, Coppings RJ, Speller-Henderson L. Most Americans are not prepared to ensure food safety during power outages and other emergencies. Food Prot Trends. 2011 Jul;31(7):428-36.
Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy (New York). 2008 Sep 1;87(3):342-9.
Cates SC, Kosa KM, Karns SA, Godwin S, Chambers D. Consumer storage practices for refrigerated ready-to-eat foods: results of a Web-enabled survey. Food Prot Trends. 2007 Jul;27(7):530-43.
Kosa KM, Cates SC, Post RC, Canavan J. Consumers' attitudes toward labeling food products with possible allergens. Food Prot Trends. 2004 Aug;24(8):605-11.
Cates SC, Kosa KM, Post RC, Caravan J. Consumers' attitudes toward open dating of USDA-regulated foods. Food Prot Trends. 2004 Feb;24(2):82.
Lovas K, Kalo Z, McKenna SP, Whalley D, Pentek M, Genti G. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary. Health Policy (New York). 2003 Jan 1;63(1):20.
McKenna SP, Whalley D. Assessment of biotechnology drugs: what are the issues? Letter to the editor. Health Policy (New York). 1999 Nov;49(3):195-7. doi: 10.1016/S0168-8510(99)00055-X